Inhibitor development in previously untreated patients with severe haemophilia A: a nationwide multicentre study in Finland.

about

Simultaneous bilateral total knee arthroplasty in patients with end-stage hemophilic arthropathy: a mean follow-up of 6 years.

P2860

Q49217209-DE579D65-6524-424E-B186-FA43C63CD6A9

P2860

Inhibitor development in previously untreated patients with severe haemophilia A: a nationwide multicentre study in Finland.

Item

http://www.wikidata.org/entity/Q45855530

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Inhibitor development in previ ...... multicentre study in Finland.

@en

Inhibitor development in previ ...... multicentre study in Finland.

@nl

type

Item

label

Inhibitor development in previ ...... multicentre study in Finland.

@en

Inhibitor development in previ ...... multicentre study in Finland.

@nl

prefLabel

Inhibitor development in previ ...... multicentre study in Finland.

@en

Inhibitor development in previ ...... multicentre study in Finland.

@nl

P1476

Inhibitor development in previ ...... multicentre study in Finland.

@en

P2093

K Vepsäläinen

http://www.w3.org/2001/XMLSchema#string

M Arola

http://www.w3.org/2001/XMLSchema#string

M Möttönen

http://www.w3.org/2001/XMLSchema#string

P Huttunen

http://www.w3.org/2001/XMLSchema#string

P Riikonen

http://www.w3.org/2001/XMLSchema#string

R Lassila

http://www.w3.org/2001/XMLSchema#string

R Ljung

http://www.w3.org/2001/XMLSchema#string

S Koskinen

http://www.w3.org/2001/XMLSchema#string

P2860

F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis

Switching treatments in haemophilia: is there a risk of inhibitor development?

Viral markers and use of factor products among Finnish patients with bleeding disorders.

Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011

The epidemiology of inhibitors in haemophilia A: a systematic review.

Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report.

Identifying nongenetic risk factors for inhibitor development in severe hemophilia a.

Inhibitors and prophylaxis in paediatric haemophilia patients: focus on the German experience.

Non-genetic risk factors and their influence on the management of patients in the clinic.

Genetic risk factors for inhibitors in haemophilia A.

P304

721-729

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HAE.12974

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Päivi Lähteenmäki

P577

2016-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27339837

http://www.w3.org/2001/XMLSchema#string

P921

hemophilia

hemophilia A

Finland

Inhibitor development in previously untreated patients with severe haemophilia A: a nationwide multicentre study in Finland.

about

P2860

P2860

Inhibitor development in previously untreated patients with severe haemophilia A: a nationwide multicentre study in Finland.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921